Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (19 ops.)
Latest filing published 29 Mar 2018 for Diplomat Pharmacy, Inc..
Filing timeline
BuySaleJoel Saban
Insider track record
Disclosed buys
1
Disclosed sells
19
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joel Saban: trading record in brief
Joel Saban is a declared insider at 2 companies; the most frequent names are SXC Health Solutions Corp. and Diplomat Pharmacy, Inc. In total, 40 filings cover trades dated from 8 September 2011 to 27 March 2018.
The open-market side counts 1 purchase for €130k alongside 19 sales for €2.2M. Sales outweigh purchases by €2.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants and 13 option exercises.
Most recently, on 29 March 2018, the filings show a share grant in Diplomat Pharmacy, Inc. The last insider purchase was made public on 20 November 2017, 3,259 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joel Saban
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
20,000 shares0Common StockSEC:0001596771-18-000039:0
10,000 shares@ US$15.24100.0% of flowCommon StockSEC:0001500814-17-000005:0
Canonical exit: 18 Feb 2018 (T+90)
54,437 shares@ US$61.50Common shareSEC:0001209191-15-062277:0
2,000 shares@ US$48.33Common shareSEC:0001209191-15-025065:0
938 shares@ US$47.89Common shareSEC:0001209191-15-025065:1
4,005 shares@ US$48.57Common shareSEC:0001209191-15-024777:0
5,740 shares@ US$48.35Common shareSEC:0001209191-15-024777:1
1,892 shares@ US$47.96Common shareSEC:0001209191-15-024777:2
16,000 shares@ US$49.65Common shareSEC:0001209191-15-023693:0
7,345 shares@ US$49.60Common shareSEC:0001209191-15-023693:1
2,434 shares@ US$48.58Common shareSEC:0001209191-15-023693:2
4,900 shares@ US$48.66Common shareSEC:0001209191-14-056755:0
1,697 shares@ US$48.92Common shareSEC:0001209191-14-056755:1
12,405 shares@ US$45.34Common shareSEC:0001209191-14-022928:0
2,595 shares@ US$46.07Common shareSEC:0001209191-14-022928:1
2,000 shares@ US$44.36Common shareSEC:0001209191-14-019005:0
2,073 shares@ US$44.67Common shareSEC:0001209191-14-019005:1
654 shares@ US$45.25Common shareSEC:0001209191-14-019005:3
6,160 shares@ US$44.70Common shareSEC:0001209191-14-018470:0
2,000 shares@ US$44.62Common shareSEC:0001209191-14-018470:2
2,005 shares@ US$44.62Common shareSEC:0001209191-14-018470:3
662 shares@ US$44.52Common shareSEC:0001209191-14-018470:4
703 shares@ US$44.52Common shareSEC:0001209191-14-018470:5
4,900 shares@ US$55.65Common shareSEC:0001209191-13-043658:0
1,654 shares@ US$54.99Common shareSEC:0001209191-13-043658:1
25 of 37 declarations
